Since 1948, the World Health Organization has been publishing the (ICD), a coded system of causes of disease and death with an in-depth revision every 10-15 years. In its latest revision, the ICD-11 uses nomenclature characterizing old age as "initial and final geriatric periods," implying the medicalization of this stage of life, which has created confusion and sparked controversy. This article discusses the new nomenclature proposed, given the current knowledge about old age and the aging process and its most accepted definition. The ICD not only classifies diseases but periods of life and "health-related problems," and old age is not a health-related problem for many people at this stage of life. It is therefore essential to change or provide a more nuanced definition of the term "old age" in the ICD-11, so it is not perceived as a symptom, sign, or anomalous clinical outcome, and to introduce nomenclature that more accurately reflects pathological aging. Two terms that are enjoying growing experimental and bibliographic support are "fragility" and "loss of intrinsic capacity," which offer greater precision when defining the condition of a person who is not experiencing healthy aging.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369127 | PMC |
http://dx.doi.org/10.26633/RPSP.2021.112 | DOI Listing |
Int J Nurs Knowl
December 2024
Professor of Department of Nursing, Faculty of Nursing, Physiotherapy and Podiatry at the University of Seville, Seville, Spain.
Objective: To increase the level of evidence available for the nursing diagnosis "Frail Elderly Syndrome 000257" through content validation by nurses with expertise in caring for the elderly.
Method: Diagnostic content validation study in accordance with Fehring's proposal composed of two stages: integrative review of the literature according to Whittemore and Knafl's guidelines, which allowed us to update the diagnostic components, and, subsequently, expert consensus study by means of the Delphi method. A total of 61 nurses who met the inclusion criteria were included.
Biosens Bioelectron
December 2024
School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China; Zhengzhou Industrial Technology Research Institute of Shanghai Jiao Tong University, Zhengzhou, 450016, China. Electronic address:
Antimicrobial resistance (AMR) has become an increasingly severe threat to global health, and AMR-associated infection is one of the leading causes of death around the world. Due to the long turnaround time and the limited flexibility and availability of current antimicrobial susceptibility testing (AST) methods, a large portion of patients with bacterial infections are still treated empirically, increasing the risk of mistreatment. To address the demand for precision treatment of bacterial infections, we developed a nano-dilution SlipChip (nd-SlipChip)-based systematic evaluation method, which facilitates rapid, logic feedback for the assessment of antibiotics, antibiotic combinations, and phage therapy.
View Article and Find Full Text PDFBiosens Bioelectron
December 2024
Department of Life Sciences, Università Degli Studi di Modena e Reggio Emilia, Via Campi 103, Modena, 41125, Italy; Center for Translational Neurophysiology of Speech and Communication, Istituto Italiano di Tecnologia (CTNSC), Via Fossato di Mortara 17-19, Ferrara, 44121, Italy.
According to the Food and Agriculture Organization of the United Nations (FAO) more than 14% of the world's food production is lost every year before reaching retail, and another 17% is lost during the retail stage. The use of the expiration date as the main estimator of the life-end of food products creates unjustified food waste. Sensors capable of quantifying the effective food freshness and quality could substantially reduce food waste and enable more effective management of the food chain.
View Article and Find Full Text PDFCompr Rev Food Sci Food Saf
January 2025
School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
The early stages of human development are critical for growth, and exposure to arsenic, particularly through the placenta and dietary sources, poses significant health risks. Despite extensive research, significant gaps remain in our comprehension of regional disparities in arsenic exposure and its cumulative impacts during these developmental stages. We hypothesize that infants in certain regions are at greater risk of arsenic exposure and its associated health complications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!